Literature DB >> 30649273

Reproducibility and accuracy of late gadolinium enhancement cardiac magnetic resonance measurements for the detection of left atrial fibrosis in patients undergoing atrial fibrillation ablation procedures.

Andrei D Mărgulescu1,2, Marta Nuñez-Garcia3, Francisco Alarcón1, Eva M Benito1, Norihiro Enomoto1, Jennifer Cozzari1, Fredy Chipa1, Hael Fernandez1, Roger Borras1, Eduard Guasch1,4, Constantine Butakoff3, Jose M Tolosana1, Elena Arbelo1, Oscar Camara3, Lluís Mont1,4.   

Abstract

AIMS: Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) may define left atrial (LA) anatomy and structural remodelling, and facilitate atrial fibrillation (AF) ablation. We aimed to assess the intra- and inter-observer reproducibility and agreement of LGE-CMR parameters with direct application to AF ablation techniques. METHODS AND
RESULTS: One experienced and one non-experienced observer performed complete LGE-CMR data analysis twice, on different days, in 40 randomly selected LGE-CMR examinations [20 performed before ablation (pre-ablation) and 20 performed 3 months after ablation (post-ablation)]. Four additional observers (two experienced and two non-experienced) performed complete LGE-CMR data analysis in a subgroup of 30 patients (15 pre-ablation and 15 post-ablation). All LGE-CMR were performed in sinus rhythm. Intra- and inter-observer reproducibility of LA volume, LA area, and sphericity index (SI) was high: coefficient of variation <10% and intraclass correlation coefficient >0.71. Geometric congruency of repeated reconstruction of LA shape was high: maximal error <5 mm for intra-observer and <8 mm for inter-observer. The precision of scar location increased with extent of scar, and was high (Dice coefficient >0.75) when the scar area was >5 cm2 for a single observer and >15 cm2 for multiple observers. Non-experienced observers performed equally well to experienced observers.
CONCLUSION: Late gadolinium enhancement cardiac magnetic resonance measurements of LA area, volume, and SI were reproducible, and geometric congruency of LA shape was high. Location of scar was precise for scar areas >5 cm2 for single observers and >15 cm2 for multiple observers, regardless of the observers' experience. These results may serve as a reference for future studies on the role for substrate-based AF ablation procedures. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Atrial fibrosis; Cardiac magnetic resonance; Delayed gadolinium enhancement; Reproducibility

Year:  2019        PMID: 30649273     DOI: 10.1093/europace/euy314

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  9 in total

1.  Left atrial evaluation by cardiovascular magnetic resonance: sensitive and unique biomarkers.

Authors:  Dana C Peters; Jérôme Lamy; Albert J Sinusas; Lauren A Baldassarre
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2021-12-18       Impact factor: 6.875

Review 2.  Current progress of computational modeling for guiding clinical atrial fibrillation ablation.

Authors:  Zhenghong Wu; Yunlong Liu; Lv Tong; Diandian Dong; Dongdong Deng; Ling Xia
Journal:  J Zhejiang Univ Sci B       Date:  2021-10-15       Impact factor: 3.066

Review 3.  The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Authors:  Pedro Silva Cunha; Sérgio Laranjo; Jordi Heijman; Mário Martins Oliveira
Journal:  Front Cardiovasc Med       Date:  2022-07-04

4.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

5.  Left ventricular wall thickness assessed by cardiac computed tomography and cardiac resynchronization therapy outcomes.

Authors:  Vincent Galand; Brian Ghoshhajra; Jackie Szymonifka; Saumya Das; Mary Orencole; Valentin Barré; Raphaël P Martins; Christophe Leclercq; Judy Hung; Quynh A Truong; Jagmeet P Singh
Journal:  Europace       Date:  2020-03-01       Impact factor: 5.214

6.  Association of left atrial strain by cardiovascular magnetic resonance with recurrence of atrial fibrillation following catheter ablation.

Authors:  Mina M Benjamin; Naeem Moulki; Aneeq Waqar; Harish Ravipati; Nancy Schoenecker; David Wilber; Menhel Kinno; Mark Rabbat; Thriveni Sanagala; Mushabbar A Syed
Journal:  J Cardiovasc Magn Reson       Date:  2022-01-03       Impact factor: 5.364

Review 7.  Strain Echocardiography to Predict Postoperative Atrial Fibrillation.

Authors:  Francisco Javier Sánchez; Esther Pueyo; Emiliano Raúl Diez
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

Review 8.  Ablation Lesion Assessment with MRI.

Authors:  Lluís Mont; Ivo Roca-Luque; Till F Althoff
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04

9.  Effect of DrOnedarone on atrial fibrosis progression and atrial fibrillation recurrence postablation: Design of the EDORA randomized clinical trial.

Authors:  Nassir F Marrouche; Lilas Dagher; Oussama Wazni; Nazem Akoum; Moussa Mansour; Abdel Hadi El Hajjar; Arezu Bhatnagar; He Hua
Journal:  J Cardiovasc Electrophysiol       Date:  2021-11-02       Impact factor: 2.942

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.